RESECTABLE PANCREATIC ADENOCARCINOMA
Clinical trials for RESECTABLE PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to boost immune system against pancreatic cancer before surgery
Disease control OngoingThis study is testing a four-drug combination given to patients before surgery for pancreatic cancer that can be removed. The treatment includes two standard chemotherapy drugs and two newer immunotherapy drugs designed to help the body's immune system fight the cancer. The main …
Matched conditions: RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for pancreatic cancer: could chemo before surgery save more lives?
Disease control OngoingThis large Phase 3 trial is comparing two different timing strategies for chemotherapy in people with pancreatic cancer that can be surgically removed. It tests whether giving strong chemotherapy both before and after surgery leads to better survival and cancer control than the s…
Matched conditions: RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC